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Impact of functional inorganic nanotubes 
f-INTs-WS2 on hemolysis, platelet function 
and coagulation
Julie Laloy1,2* , Hélène Haguet2,3 , Lutfiye Alpan1,2, Daniel Raichman4, Jean‑Michel Dogné1,2 
and Jean‑Paul Lellouche4*
Abstract 
Inorganic transition metal dichalcogenide nanostructures are interesting for several biomedical applications such as 
coating for medical devices (e.g. endodontic files, catheter stents) and reinforcement of scaffolds for tissue engineer‑
ing. However, their impact on human blood is unknown. A unique nanomaterial surface‑engineering chemical meth‑
odology was used to fabricate functional polyacidic polyCOOH inorganic nanotubes of tungsten disulfide towards 
covalent binding of any desired molecule/organic species via chemical activation/reactivity of this former polyCOOH 
shell. The impact of these nanotubes on hemolysis, platelet aggregation and blood coagulation has been assessed 
using spectrophotometric measurement, light transmission aggregometry and thrombin generation assays. The func‑
tionalized nanotubes do not induce hemolysis but decrease platelet aggregation and induce coagulation through 
intrinsic pathway activation. The functional nanotubes were found to be more thrombogenic than the non‑functional 
ones, suggesting lower hemocompatibility and increased thrombotic risk with functionalized tungsten disulfide 
nanotubes. These functionalized nanotubes should be used with caution in blood‑contacting devices.
Keywords: Functional tungsten disulfide nanotubes, Safety, Hemocompatibility, Thrombin generation
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1 Introduction
Inorganic transition metal dichalcogenide (TMD) mate-
rials, such as tungsten and molybdenum disulfides 
 (WS2 and  MoS2, respectively) are of significant inter-
est to the scientific community because of their unique 
multi-layered structures and functional properties, 
with nano-sized fullerene-like (IF) particles tending to 
exhibit a different set of properties compared to the 
corresponding bulk forms. These metal dichalcogenide 
nanomaterials have emerged as one of the most promis-
ing classes of nanomaterials since the discovery of car-
bon nanotubes (CNTs) [1–8]. As with early researches 
in the field of CNTs, a wide number of potential appli-
cations have been proposed and investigated including 
areas such as energy storage [9], field effect transistors 
[10], nanocomposite coatings [11, 12], battery anodes 
[13], light-emitting diodes [14], self-lubricating medical 
devices [15], and high-performance nanoscale lubricants 
[16–23]. In addition, the outstanding shock absorb-
ing ability of IFs-WS2 nanotubes holds a great potential 
for new impact and shock-resistant materials [24–26]. 
Composite hybrid materials formed by incorporating 
small amounts (less than 5% weight ratios) of such nano-
sized inorganic fillers into any given polymer matrix are 
also of particular interest, showing improved mechani-
cal properties, higher thermal properties, and improved 
performances as barriers to heat, moisture, and solvents 
[27–29] when compared to similar composites prepared 
with conventional fillers [28, 30]. Indeed, considerable 
research work has been conducted dealing with poly-
mer-based nanocomposites that incorporate inorganic 
IFs-WS2 NPs into matrices of epoxy [30], polystyrene/
poly(methylmethacrylate) [28], poly(propylene fuma-
rate) [29], nylon 12 [31], and poly(phenylene) sulphide 
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[32]. Due to the superior mechanical properties of cor-
responding inorganic IFs-WS2 NPs, such as high stiffness 
and strength [33], ultrahigh-performance polymer nano-
composites have been readily produced [34]. In addition, 
commercial performant lubricants are now presently 
available that include same inorganic IFs-WS2 NPs that 
impart unique tribological properties [35] to the corre-
sponding final composite products. Although there are 
many potential applications in a wide variety of fields for 
such inorganic metal dichalcogenide IFs-WS2 NPs and 
inorganic INTs-WS2 nanotubes (INTs), novel develop-
mental research has been strongly hampered analogously 
to early CNTs-based research. Indeed, these dichalcoge-
nide nanomaterials are highly hydrophobic, thus quite 
insoluble in common organic/aqueous solvents, difficult 
to homogeneously disperse into most liquids and resins, 
while disclosing serious limited dual phase compatibility 
when admixed with common polymers.
In this specific context, we recently developed a unique 
nanomaterial surface-engineering chemical methodology 
to fabricate covalently decorated functional polyacidic 
polyCOOH–INTs-WS2 using Vilsmeier–Haack (VH) 
complex chemistry/reactivity (polyCOOH shell decora-
tion) [36]. This novel surface engineering method ena-
bles effective covalent bonding of any desired molecule/
organic species via polyCOOH shell chemical activation/
reactivity that may improve and optimize any requested 
interfacial property of corresponding functional INTs-
WS2 (f-INTs-WS2). This polycarboxylated shell can be 
readily exploited as an anchoring shell for subsequent 
second-step covalent attachment of a wide variety of 
organic molecules/polymers, including even other com-
ponents such as NPs, for example, onto the functional 
nanotube surface. Therefore, a quite versatile simple 
organic activation chemistry (EDC•HCl activation of 
polyCOOH shell/species) readily enables corresponding 
surface property tuning to match those requested for any 
contacting material (polymeric phases, solvents, etc.). 
Moreover and in this context, by employing appropriate 
bifunctional linkers such as those described in this study 
(obtainment of novel 2nd step  polyNH2/polySH/polyOH 
shells, Fig.  1), the resulting chemically modified f-INT-
WS2 can be covalently bound to an even wider variety of 
reactivity-complementing materials.
Recent progress in studies of this original novel class 
of inorganic nanomaterials suggests that they can be also 
impregnated into metallic coatings for medical admin-
istration/application [37]. For example, it was demon-
strated that the use of orthodontic wires coated with 
metallic films containing IFs-WS2 NPs in dentistry could 
significantly reduce the mechanical forces required for 
teeth realignment, thus preventing unnecessary excess 
forces that would lead to unacceptable teeth movement, 
longer treatment, and adverse damage to the roots of the 
teeth [10, 37, 38].
Since both IFs-WS2 NPs and INTs-WS2 are already 
commercially available in the market thus providing 
effective potentialities of incorporation/involvement 
towards innovative future medical applications, extensive 
research investigations concerning the overall biocom-
patibility and toxicity of these inorganic materials need 
to be performed to ensure that they are safe for com-
posite-based usage. Researches on the toxicity of TMD 
nanomaterials is still in its infancy with only a hand-
ful of assessments performed on IFs-MoS2 and IFs-WS2 
NPs. Preliminary results from in vivo toxicology tests of 
IFs-WS2 NPs showed no apparent toxic effects on mam-
mals, suggesting its high biocompatibility [39]. In addi-
tion, in  vitro cytotoxicity examination of IFs-MoS2 NPs 
on three different human cell lines (i.e. CCC-ESF-1, 
Fig. 1 Preparation of functional polyX (X: COOH,  NH2, OH, SH) f‑INT‑WS2 inorganic nanotubes. The functional inorganic nanotubes were prepared 
using electrophilic VH complex and subsequent covalent chemical derivatizations
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A549, and K562) revealed that they are nontoxic to cells 
after 48  h exposure [17]. However, at the present time, 
no experimental studies assessed the hemocompatibility 
of TMD materials. With the influx of research and pos-
sible commercialization of TMDs in the future, it is vital 
to both initiate hemocompatibility studies of this group 
of nanomaterials and assess their impact on hemolysis, 
platelet functions, and blood coagulation [40].
In this special work, we characterized the hemocom-
patibility of such different functional INTs-WS2 and 
assessed their impact on red blood cells, platelet aggrega-
tion and blood coagulation using human blood.
2  Methods
2.1  Materials
Non-functional INTs-WS2 have been bought from Nano-
Materials Ltd. Company (Yavne, Israel). All reagents and 
solvents have been purchased from commercial sources 
and used without any further purification. Thermogravi-
metric analyses (TGA) have been performed on a TA 
Q600-0348, model SDT Q600 (Thermofinnigan) device 
using a temperature profile of 25–800  °C at 10  °C/min 
under nitrogen flow (180 mL/min) with sample amounts 
of 5–15  mg. Infrared (IR) spectra were recorded on 
a Fourier transform infrared spectrometer Tensor 27 
(Bruker) using attenuated total reflectance (ATR). Nano-
material surface charges were evaluated by ξ potential 
measurements using a Zetasizer Nano-ZS device (Mal-
vern Instruments Ltd., United Kingdom) in water (pH 
adjusted) at 25 °C and 150 V. Both VH-untreated starting 
and resulting VH-modified f-INTs-WS2 nanotubes have 
been also characterized using G2, FEI High Resolution 
transmission electron microscopy (TEM) (Tecnai). Dis-
persions of INT-WS2 and f-INT-WS2 have been prepared 
with a low-power ElmaSonic S30 bath sonicator (Elma 
GmbH & Co., Deutschland). The chemically accessi-
ble polyCOOH shell present on the surface of the poly-
COOH f-INT-WS2 has been also quantified by both (i) 
Kaiser testing after shell derivatization using 1,3-diami-
nopropane and (ii) Ellman’s one after subsequent similar 
shell derivatization using cysteamine.
2.2  Polycarboxylation of INT‑WS2—fabrication 
of polyCOOH‑f‑INT‑WS2
To a solution of 2-bromoacetic acid (2-BrCH2COOH), 
(1.0  g, 7.19  mmol) in anhydrous dimethyl formamide 
(DMF, 3 mL) was added Ag(I)OAc (10.0 mg, 0.059 mmol) 
and dry INT-WS2 (200.0 mg). The mixture was heated in 
an oil bath to 80  °C and stirred over 2 days at the same 
temperature. After cooling to room temperature, the 
mixture was centrifuged (11,000 rpm, 5 min). The result-
ing cleaned (EtOH, 5 washing cycles) solids were dried 
under vacuum to obtain 190 mg of functional polyCOOH 
f-INT-WS2.
2.3  Diamine coupling onto polyCOOH f‑INT‑WS2—
fabrication of  polyNH2‑f‑INT‑WS2
To a solution of 1-ethyl-3-(3-dimethylaminopropyl)car-
bodiimide (EDC, 20.0  mg, 4  mmol) in dichlorometh-
ane (DCM, 12  mL) was added polyCOOH f-INT-WS2 
(200.0  mg) and 4-dimethylaminopyridine (DMAP, 
10.0 mg, 0.08 mmol). The mixture was stirred for 2 h at 
room temperature followed by addition of 1,3-diamino-
propane  (NH2–(CH2)3–NH2, 800  µL, 9.58  mmol) and 
stirring continued at room temperature overnight. The 
mixture was centrifuged (11,000  rpm, 5  min) and the 
supernatant discarded. The solids were worked up as 
described for former polyCOOH f-INT-WS2. The prod-
uct contained 0.77  mmol  NH2 groups/g of  polyNH2 
f-INT-WS2 as determined by Kaiser testing.
2.4  Cysteamine coupling onto polyCOOH f‑INT‑WS2—
fabrication of polySH‑f‑INT‑WS2
To a solution of EDC (3.0 g, 19.32 mmol) in DCM (40 mL) 
was added polyCOOH f-INT-WS2 (1.8 g). The suspension 
was stirred for 2 h at room temperature followed by addi-
tion of cysteamine  (NH2–(CH2)2–SH, 4.0 g, 51.85 mmol) 
and DMAP (20.0 mg, 0.16 mmol) and stirring continued 
for 2 days at room temperature. The mixture was centri-
fuged (11,000 rpm, 5 min) and the supernatant discarded. 
The solids were worked up as described for former poly-
COOH f-INT-WS2 to obtain 1.6 g of functional product. 
The product contained 0.8 mmol SH groups/g of polySH 
f-INT-WS2, as determined by Ellman testing.
2.5  2‑Aminoethanol coupling onto polyCOOH f‑INT‑WS2—
Fabrication of polyOH‑f‑INT‑WS2
To a solution of EDC (3.0  g, 19.32  mmol) in DCM 
(40  mL) was added polyCOOH f-INT-WS2 (1.5  g). The 
suspension was stirred for 2 h at room temperature fol-
lowed by addition of 2-aminoethanol  (NH2–(CH2)2–OH, 
4.0  mL, 64.71  mmol) and DMAP (20.0  mg, 0.16  mmol) 
and stirring continued for 2  days at room temperature. 
The mixture was centrifuged (11,000  rpm, 5  min) and 
the supernatant discarded. The solids were worked up as 
described for former polyCOOH f-INT-WS2 to obtain 
1.3 g of functional product.
2.6  Preparation of human platelet‑rich plasma, 
platelet‑poor plasma, normal pooled plasma 
and washed red blood cells suspension
Human platelet rich plasma (PRP), platelet poor plasma 
(PPP), whole blood, washed red blood cell (RBC) suspen-
sion and normal pool plasma (NPP) were prepared with 
blood from healthy volunteers who were free from any 
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medication for at least 2  weeks. Blood was collected by 
venipuncture into tubes containing buffered sodium cit-
rate (109 mM, nine parts blood to one part of sodium cit-
rate solution) (BD  Vacutainer®). The study protocol was 
in accordance with the Declaration of Helsinki and was 
approved by the Medical Ethical Committee of the CHU 
UCL Namur (Yvoir, Belgium).
PRP was carefully prepared by centrifugation at 200g of 
whole blood at room temperature for 10 min. The platelet 
count was adjusted to 300,000 platelets/μL and PRP was 
used immediately after preparation. Platelet free plasma 
used to adjust platelet concentration is obtained after 
centrifugation at 2000g in 10  min of the pellet at room 
temperature.
The preparation of washed RBC suspension was pre-
pared by centrifugation of whole blood at 3000g over 
5  min. The PPP is removed and used for interference 
assays. RBC are washed with physiological phosphate 
buffered saline (PBS, 6.7 mM phosphate, pH = 7.4) three 
times with intermediate centrifugation of 3000g over 
5 min. RBC are then resuspended in PBS with the same 
volume as PBS removed.
For NPP, a total of 47 healthy individuals were included 
in the study. The exclusion criteria were thrombotic and/
or hemorrhagic events, antiplatelet and/or anticoagulant 
medication, pregnancy and uptake of drugs potentially 
affecting the platelet and/or coagulation factor functions 
during the 2 weeks prior to the blood drawn. A written 
informed consent was obtained from each donor. The 
study population displayed the following characteris-
tics: 27 females and 20 males aged from 18 to 53  years 
(mean age = 25 years) with body mass index (BMI) rang-
ing from 17.6 to 34.9  kg/m2 (mean BMI = 22.7  kg/m2). 
After collection of blood, the PPP was obtained from the 
supernatant fraction of the blood tubes after a double 
centrifugation for 15 min at 2000g at room temperature. 
It was immediately frozen at − 80  °C after centrifuga-
tion. The NPP samples were thawed and kept at 37 °C just 
before use.
2.7  Hemolysis assays
Hemolysis assays were performed as previously described 
on the blood of one healthy donor [41]. Briefly, 15  μL 
of nanomaterial suspended in tyrode, tyrode (negative 
control) or triton X-100 (positive control) are added to 
285 μL of whole blood or washed RBC (final NP concen-
tration: 100 µg/mL). The suspension is incubated at room 
temperature on a shaking plate during 1  h. After the 
incubation time, the suspension is centrifuged at 10,000g 
over 5 min. Supernatant is read in a 96-well plate using a 
microplate scanning spectrophotometer XMark (Biorad, 
USA) at 550 nm. The percentage hemolysis was then cal-
culated as:
For each term of the equation, the corresponding 
interference was subtracted. The interference 
corresponds to the same conditions except that the 
solution does not contain RBCs. Positive (triton X − 100 
at 1%) and negative (Tyrode) controls induced 100% and 
0% of hemolysis, respectively. The results were expressed 
as mean ± SD (n = 3).
2.8  Light transmission aggregometry
The impact of f-INTs-WS2 on induced platelet aggre-
gation was studied using the chronometric aggregom-
eter type 490-2D as previously reported [41]. Briefly, 
the reaction mixture for induced aggregation tests con-
tained 213 or 233  μL of PRP at 300,000 platelets/μL, 
with respectively 25  μL of collagen (final concentration: 
190 μg/mL, calf skin, Bio/Data corporation, USA) or 5 μL 
of arachidonic acid (AA, final concentration: 600  μM, 
Calbiochem, Germany) and 12.5 μL of NPs at final con-
centration of 100 μg/mL. Inducers alone were also used 
before any experiment to check platelet reactivity. PPP 
was used as a reference. Data were collected with the 
chronolog two channel recorders at 405 nm connected to 
a computer.
2.9  Coagulation: calibrated thrombin generation test 
(cTGT)
The impact of non-functional and functional INTs-WS2 
on coagulation was studied using the calibrated throm-
bin generation test (cTGT) as previously reported [41]. 
For each experiment, a fresh mixture of fluorogenic sub-
strate/calcium chloride buffered solution was prepared as 
follows: 2.6 mL of Fluo  Buffer® (Thrombinoscope BV, The 
Netherlands) were mixed with 65 μL of Fluo  substrate® 
(100  mM in DMSO, Thrombinoscope BV, The Nether-
lands). PPP-Reagent, PPP-Reagent LOW, MP-Reagent 
and Thrombin Calibrator (Thrombinoscope BV, The 
Netherlands) are four inducers, giving final assay concen-
trations of 5 pM tissue factor (TF) with 4 μM phospho-
lipids (PL) and 16.7 mM  CaCl2; 1 pM TF with 4 μM PL 
and 16.7 mM  CaCl2; 4 μM PL and 16.7 mM  CaCl2; and 
620  nM α2- macroglobulin-thrombin complex, respec-
tively. They are reconstituted with 1  mL distilled water 
according to the instructions provided by the manufac-
turer. A calibration curve was simultaneously performed 
using the thrombin calibrator. The acquired data were 
automatically processed by the software, which provided 
thrombin activity curves and 3 parameters based on this 
curve: lagtime (minutes), peak concentration (nM) and 






ODTritonX−100 at 1% − ODtyrode
) × 100.
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The INT/f-INTs suspensions were tested at final concen-
trations from 5 to 500  μg/mL. Statistical analyses were 
conducted with an unpaired t-test using the GraphPad 
Prism software (GraphPad software, v 5.01, USA).
3  Results
3.1  Fabrication and characterization of f‑INTs‑WS2
Functional INTs-WS2 have been effectively fabricated 
using the two-step surface engineering methodology 
described in Fig.  1 below. First and as the first critical 
chemical modification methodology, a strongly electro-
philic VH complex arising from DMF–BrCH2COOH 
reactivity has been generated in  situ in the presence of 
starting INTs-WS2 to provide intermediate polyacidic 
functional polyCOOH f-INTs-WS2.
In a 2nd derivatization step, resulting chemically modi-
fied polyCOOH f-INTs-WS2 nanotubes might be readily 
chemically activated (EDC activation) and reacted with 
bifunctional nucleophilic linkers of the type H2N-link-
X to provide corresponding functional polyX  (polyNH2, 
polySH, polyOH) f-INTs-WS2 nanotubes. All these func-
tional nanomaterials have been fully characterized by 
combined thermogravimetric analysis (TGA), spectro-
scopic FT-IR/XPS, XRD, Kaiser  (NH2 species quantifica-
tion)/Ellman (SH species quantification) tests, HR-TEM 
and ζ potential values measurements (Table 1). All these 
characterization spectroscopy-based spectra/data and 
TEM/HR-TEM microphotographs including nanomate-
rials are fully detailed in the corresponding Ref. [36].
3.2  Hemocompatibility
3.2.1  Red blood cells
Absorbance spectrum of RBC suspension 10% (v/v) 
supernatant incubated with Triton X-100 1% (v/v) is 
measured. The interference of nanotubes within assay is 
determined at 550 nm. This interference was avoided by 
subtracting the  OD550 nm of INTs-WS2/f-INTs-WS2 sus-
pended in the vehicle from the measured  OD550  nm at 
the same concentration (data not shown). Measurement 
of absorbance at 550 nm in whole blood or washed RBC 
supernatant assesses the release of hemoglobin from lysis 
RBCs. Both non-functionalized and functionalized INTs-
WS2/f-INTs-WS2 at 100  µg/mL did not induce hemoly-
sis in whole blood (Fig.  2a) and in washed red blood 
cells (Fig. 2b) according to the ASTM E2524-08 standard 
(hemolysis ratio of all samples was below 5%) [42].
3.2.2  Platelet function
Second important parameter to be determined is the 
impact on platelet and in particular on platelet aggrega-
tion. At 100  µg/mL, non-functionalized and function-
alized INTs-WS2/f-INTs-WS2 significantly decreased 
platelet aggregation induced by AA (Fig.  3b). When 
collagen is the inductor, only polyCOOH-f-INTs-WS2 
decreased significantly platelet aggregation (Fig. 3a).
3.2.3  Coagulation
Impact of f-INTs-WS2 on blood coagulation was assessed 
through cTGT. Non-functionalized and functionalized 
INTs-WS2/f-INTs-WS2 impact blood coagulation when 
the intrinsic pathway is triggered (Fig. 4). A procoagulant 
effect of these nanomaterials is observed with a decrease 
of lagtime and an increase of peak concentration and ETP 
(Table  2). Based on their procoagulant activity on the 
intrinsic pathway, INTs-WS2/f-INTs-WS2 can be clas-
sified as follows:  WS2-NH2 > WS2-OH > WS2-SH=WS2-
COOH > WS2. Experiments with coagulation initiated 
by the extrinsic and common pathways demonstrated no 
effect of f-INTs-WS2 at the exception of polyNH-f-INTs-
WS2 which had a procoagulant effect when common 
pathway is triggered (data not shown).
4  Discussion
As quite novel inorganic multi-layered nanomaterials, 
hydrophobic non-functional INTs-WS2 nanotubes have 
been recently shown to be reactive towards a strongly 
Table 1 Selected characterization (TGA) and functionality quantification data
INTs, inorganic nanotubes; TGA, thermogravimetric analysis—starting INTs-WS2 nanotubes are negatively charged (− 25.0 mV) due to known OH-based defects 
arising from industrial nanofabrication step




INTs‑WS2 – – ~ 3% − 25.0
INTs‑WS2COOH – – 11% − 34.7
INTs‑WS2NH2 0.77 – 19% − 18.9
INTs‑WS2SH – 0.8 14% − 28.4
INTs‑WS2OH – – 12% − 27.2
INTs‑WS2OH: specific characterizing 
IR data
[2683–3190–3525 cm−1]: O–H stretchings set (OH organic species); 1620 and 1520 cm‑1: C=O stretchings of 
carbonyl and amide species; 1520 cm−1: C–H stretchings (saturated aliphatic species)
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electrophilic acidic VH complex arising from both DMF/
Br-CH2COOH reagents that enabled stable covalent 
nanotube surface chemical engineering/chemical modifi-
cation by a corresponding polyCOOH shell (polyCOOH 
f-INTs-WS2 nanotubes). Quite innovatively while using 
specific bifunctional linkers (Fig. 1), this polyacidic shell 
might be readily exploited via EDC activation for addi-
tional surface engineering to get a wide variety of func-
tional f-INTs-WS2 inorganic nanotubes, i.e.,  polyNH2/
polySH/polyOH f-INTs-WS2 nanotubes [36]. It must be 
noticed that this innovative covalent surface engineering 
enables the quite effective development of any requested 
appropriate interfacial surface feature (surface reac-
tive functionality, surface hydrophobicity/hydrophilicity 
Fig. 2 Impact of INTs‑WS2/f‑INTs‑WS2 on hemolysis after 1 h at 100 μg/mL. Experiments were performed on a whole blood and b washed RBC. 
Triton X‑100 1% and Tyrode buffer (v/v) were respectively used as positive and negative controls. Mean (%) ± SD, n = 3
Fig. 3 Effect of functionalized INTs‑WS2 at 100 µg/mL on platelet aggregation. Platelet aggregation was induced by (a) collagen or (b) AA. Tyrode 
was used as a negative control. Results are expressed as % of response (Mean ± SD, n = 2–4)
Fig. 4 Thrombin activity profiles in the presence of 
INTs‑WS2/f‑INTs‑WS2 at 100 µg/mL. Data represent the mean of three 
independent experiments
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balance) when incorporated into any polymeric matrix 
for example.
Before being used in human, biocompatibility of blood 
contacting devices needs to be considered to detect 
potential deleterious effects. Cytotoxicity studies have 
been initiated with TMD nanomaterials and first results 
are encouraging. In  vitro studies have been conducted 
in different cellular models and do not demonstrate  WS2 
nanotubes induced cytotoxicity [43, 44]. Teo Chng con-
firmed this safety profile and demonstrates that  WS2 is 
the least toxic of TMD nanomaterials [45]. In vivo studies 
in murine models confirmed the safety of these particles 
[46, 47]. In addition to cytotoxicity studies, hemocompat-
ibility assays are also part of preclinical assessment of any 
biomedical device according to ISO-10993-4. Common 
hemocompatibility testing includes hemolysis, platelet 
function, and coagulation assays. The hemocompatibil-
ity of TMD is to our knowledge currently unknown. For 
the first time, we are reporting here the impact of non-
functional/functional INTs-WS2/f-INTs-WS2 on human 
blood. Additionally, physicochemical properties of nano-
materials (e.g. NP shape, hydrophilicity, solubility, size, 
chemical composition) are linked to toxic outcomes. As 
a matter of direct consequence, it has been quite attrac-
tive to determine, check, and eventually confirm how 
such versatile surface engineering functionalization shells 
might influence the hemocompatibility of corresponding 
surface-engineered INTs-WS2.
Hemolysis refers to the destruction of red blood cells 
inducing release and buildup of toxic red blood cell con-
tent (i.e. hemoglobin), which may cause potential life-
threatening conditions (e.g. hepatic and renal injuries). 
Because of their small size, nanomaterials bind red blood 
cells and could induce by this way hemolysis [48]. There-
fore, assessment of hemolytic potential of all medical 
devices in contact with blood is required. We assessed the 
hemolytic potential of our nanomaterials using a spectro-
photometric assay suitable to study of nanomaterials (i.e. 
nanoparticle/nanotube interferences need to be ruled 
out) [49] and demonstrated that non-functionalized and 
functionalized INTs-WS2/f-INTs-WS2 do not impact 
hemolysis on human blood and washed red blood cells 
(i.e. results below the 5% threshold) in accordance to 
ISO-10993-4. Higher levels of hemolysis are reported 
in experiments with washed red blood cells compared 
to those performed in whole blood. This difference was 
previously reported with silver and silica nanoparti-
cles and is possibly related to the adsorption of human 
plasma biomolecules on nanoparticles, which possibly 
affect their hemolytic potential [41, 50]. Our results are 
in accordance with prior studies, which demonstrated no 
hemolytic effect of other TMD nanomaterials (i.e.  MoSe2 
nanosheets) [51, 52]. Li et  al. [53] demonstrated that 
coating of TiNi alloy with tungsten nanomaterial reduces 
hemolysis rate, which confirms the safety of such mate-
rials toward red blood cells [54]. Our results are also in 
accordance to prior studies that indicate that nanomate-
rials with anionic surface does not induce hemolysis [40]. 
The few effect of these nanotubes on red blood cells is 
reassuring for future biomedical applications.
Platelet function is also part of preclinical characteri-
zation and is an important parameter to predict impact 
of nanomaterials on human blood clotting. Indeed, 
hemostasis is regulated by both plasmatic coagulation 
and platelet functions and alteration of platelet func-
tions may lead to either bleeding or thrombosis [55]. 
Our study assessed platelet aggregation on human blood 
by light transmission aggregometry following activation 
by two different inducers, a suitable method to assess 
nanomaterial potential [56]. We demonstrate nonsig-
nificant decrease of collagen-induced platelet aggre-
gation by f-INTs-WS2 and also that same f-INTs-WS2 
decrease platelet aggregation when induced by arachi-
donic acid. To our best knowledge, no other investigated 
impact of such nanomaterials on platelet functions has 
been ever reported. Therefore, the mechanism by which 
Table 2 Influence of  INTs-WS2/f-INTs-WS2 at  100  µg/mL on  thrombin generation parameters induced by  the  intrinsic 
pathway
ETP, endogenous thrombin potential; NPP, normal pool plasma
Data are expressed in percentage in comparison with control (PBS) (n = 3)
4 µMPL % Lagtime % Lagtime SD % ETP % ETP SD % Peak % Peak SD
NPP 100 9 100 9 100 11
Tyrode 81 1 110 4 112 6
WS2 71 5 107 3 102 3
WS2‑COOH 58 2 114 3 113 2
WS2‑NH2 48 3 130 5 150 19
WS2‑OH 59 3 119 6 122 10
WS2‑SH 58 2 119 1 131 6
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f-INTs-WS2 induced decreased platelet aggregation is 
unknown. Potential hypothesis to explain this effect 
on platelets could be that these nanomaterials decrease 
agonist-induced activation. Additionally, the hydropho-
bicity of functional groups might be implicated in the 
decreased platelet aggregation. Indeed, Elbert and Hub-
bell have demonstrated that hydrophobic surfaces adsorb 
more proteins which might cause platelet adhesion and 
activation and therefore be responsible of blood clot [57]. 
This might explain why functionalization through addi-
tion of highly hydrophilic COOH groups reduces colla-
gen-induced platelet aggregation.
As foreign materials, biomedical devices can activate 
human blood coagulation and dysregulate hemostasis. 
Human blood coagulation is characterized by a cascade 
of sequential proteolytic reactions which can be initi-
ated by two pathways, the intrinsic and extrinsic ones, 
that both converge to thrombin generation [55]. Because 
coagulation is dependent to thrombin, we studied the 
impact of our various nanotubes on human coagulation 
through a thrombin generation assay, a suitable method 
to assess nanomaterial impact on coagulation [58] com-
pared to routine tests, which are insensitive for small 
changes [55]. An additional advantage of this test is that 
it is performed on human plasma, a protein-containing 
media which limits nanomaterial interference by their 
coating with physiological proteins [55]. We demonstrate 
that non-functional INTs-WS2 possess a procoagulant 
activity, which is accentuated by the functionalization 
feature of relating corresponding functional f-INTs-WS2 
nanomaterials. This procoagulant effect is mediated by 
activation of the intrinsic pathway while INTs-WS2 do 
not affect the extrinsic pathway (data not shown). This is 
in line with data prior studies which indicate that nano-
materials mainly activate coagulation through intrinsic 
pathway [55].
The mechanism by which f-INTs-WS2 induce 
coagulation is unknown. Numerous nanomaterial 
physicochemical properties are implicated in hemo-
compatibility and nanomaterial surface is predominant 
because of its interactions with plasma proteins [59]. 
Zeta potential is an indicator of surface charge and has 
been already used to predict nanomaterial effects on 
human health [60]. Indeed, negatively charged surfaces 
are expected to be more thrombogenic because contact 
with anionic surface initiates physiological coagula-
tion [61]. An hypothesis suggests that the procoagulant 
effect of some nanomaterials is the consequence of 
their binding capacity with coagulation factors which 
induce their activation [59]. Factor XII, a factor impli-
cated in the intrinsic pathway, is of special interest and 
might undergo self-activation after interaction with 
an anionic surface [61]. Additionally, it was already 
demonstrated that anionic carbon nanotubes effectively 
induce human coagulation through activation of the 
intrinsic pathway [55]. Therefore, the anionic proper-
ties of our INTs-WS2 may explain their prothrombotic 
activity. Additionally, functionalization of our INTs-
WS2 modifies surface properties and decreases zeta 
potential values, at the exception of  NH2-INTs-WS2 
[36]. Our study reports correlation between thrombotic 
potential of f-INTs-WS2 and their zeta potential, at the 
exception of  NH2-INTs-WS2. However, surface charges 
are difficult to interpret because of binding of proteins 
on nanomaterial surface and because zeta potential 
was determined in protein-free media (i.e. in water) 
compared to coagulation testing performed in human 
plasma. Finally, it is interesting to highlight that in our 
study, TGA weight loss correlates with TGTc peak con-
centration, with higher weight loss and procoagulant 
activity with  NH2-INTs-WS2. TGA determines the 
amount of organic material bound to the f-INTs [36]. 
Therefore and together with their unique zwitterionic 
surface charge features (mixed positive ammonium/
NH3+ charges with negative OH-based defects), one 
might speculate that  NH2-INTs-WS2 might better pro-
mote and bind highest amounts of organic materials to 
more effectively induce coagulation by better binding 
coagulation factors.
Tungsten disulfide nanostructures possess interesting 
physicochemical properties and high load bearing 
properties implying new opportunities in medicine 
[47, 62]. Potential health applications include blood-
contacting and invasive devices (e.g. medical device 
coating, drug delivery inorganic systems, reinforcement 
of scaffolds for tissue engineering) [32, 46]. Moreover 
and quite recently, same  NH2-INTs-WS2 nanomaterials 
have been successfully derivatized by nanotube surface-
localised C-quantum dots towards both (i) cancer cell 
fluorescence imaging/investigation, and (ii) quite effective 
photothermal cell killing capability (PTT therapy 
potentiality), [63] thus opening a quite attractive future 
field of PTT cancer therapy by such non-toxic inorganic 
nanotubes (nanoparticle theranostics) [64, 65]. Serious 
concerns exist about nanomaterial-induced coagulation 
disorders. Therefore, the analysis of nanomaterial toxic 
effects on human blood cells is quite mandatory. We 
demonstrated using in  vitro models that INTs-WS2 
decrease platelet aggregation and induce a procoagulant 
state that is heighten by both functionalization type and 
level of innovative functional nanotubes. This observed 
effect on coagulation can be either beneficial or adverse 
according to its applications Therefore, we recommend 
the use of the functionalized nanoparticles in applications 
that imply blood coagulation such as wound dressing.
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